Literature DB >> 19480043

Zygomatic nonunion after reduction malarplasty.

Yoon Ho Lee1, Sang Woo Lee.   

Abstract

Reduction malarplasty for making an oval facial shape is popular in Asia. Surgeons generally prefer the intraoral approach to minimize the surgical incision and reduce the operation time between 2 approaches--intraoral and bicoronal approaches. However, fixation can be incomplete because of the narrow operation field, which can result in zygomatic nonunion on the fixation site through the action of the masseter muscle. In the past 5 years, 6 zygomatic nonunion patients who received reduction malarplasty through the intraoral approach visited our hospital with a limitation of mouth opening and a depression on the malar area. In every case, they were corrected by rib bone interpositional or onlay graft and miniplate refixation through a previous intraoral incision. During the follow-up period, the malar area depression was corrected in most cases. However, depression of the lateral orbital rim area remained in 1 patient. Mouth opening was almost normalized after postoperative mouth opening exercises. Zygomatic nonunion after reduction malarplasty is a serious complication that is very difficult to correct. Deep understanding of the anatomy of the malar complex and the action of the masseter muscle and careful consideration of fixation during surgery is essential in reduction malarplasty.

Entities:  

Mesh:

Year:  2009        PMID: 19480043     DOI: 10.1097/scs.0b013e3181a2f040

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  2 in total

1.  A New Infracture Technique for Reduction Malarplasty with an L-Shaped Osteotomy Line.

Authors:  Li-Xin Lin; Ji-Long Yuan; Yu-Ting Wang; Yong Huang; Peng Wang; Xue-Ming Wang
Journal:  Med Sci Monit       Date:  2015-07-06

2.  Novel treatment of revision malarplasty with piezosurgery: A case report.

Authors:  Qiang Zhang; Caiwang Chang; Zhibing Meng; Jinhua Huang; Jun Guo; Zili Ge
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.